Dimensional Fund Advisors LP Decreases Position in Myriad Genetics, Inc.


Dimensional Fund Advisors LP decreased its position in shares of Myriad Genetics, Inc. by 13.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,642,281 shares of the company's stock after selling 412,982 shares during the period.



from Biotech News